Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Shepshelovich

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
Expert Opinion on Drug Safety|January 23, 2023
Evaluating the Impact of Black Box Warning Updates on the Reporting of Drug-Related Adverse Events: a Cross Sectional Study of the FAERS DatabaseYarden Yavne, Reut Amar Shamir, Michael Shapiro, et al.
Rheumatology (Oxford, England)|March 25, 2021
Quality evaluation of the underlying evidence in the updated treatment recommendations for systemic lupus erythematosusYarden Yavne, Yonatan Edel, Julia Berman, et al.
Acta Haematologica|August 17, 2018
Agranulocytosis Associated with Waldenström MacroglobulinemiaIuliana Vaxman, Daniel Shepshelovich, Lucille Hayman, et al.
The American Journal of Medicine|November 10, 2015
High Lung Cancer Incidence in Heavy Smokers Following Hospitalization due to PneumoniaDaniel Shepshelovich, Hadar Goldvaser, Yonatan Edel, et al.
The American Journal of Cardiology|July 19, 2020
Effect of Ticagrelor on Reducing the Risk of Gram-Positive Infections in Patients With Acute Coronary SyndromeLior Lupu, Daniel Shepshelovich, Shmuel Banai, et al.
Breast Cancer Research and Treatment|April 1, 2019
Toxicity and clinical outcomes of partial breast irradiation compared to whole breast irradiation for early-stage breast cancer: a systematic review and meta-analysisYasmin Korzets, Anthony Fyles, Daniel Shepshelovich, et al.
Mayo Clinic Proceedings|November 6, 2019
Undisclosed Financial Conflicts of Interest of Authors of Clinical Drug Trials Published in Influential Medical Journals: A Cohort StudyNoam Tau, Tzippy Shochat, Anat Gafter-Gvili, et al.
The Journal of Antimicrobial Chemotherapy|June 2, 2021
Concordance between the results of randomized and non-randomized interventional clinical trials assessing the efficacy of drugs for COVID-19: a cross-sectional studyDaniel Shepshelovich, Dafna Yahav, Ronen Ben Ami, et al.
Drug Safety|January 25, 2024
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic ReviewBronya Calvarysky, Idit Dotan, Daniel Shepshelovich, et al.
Mayo Clinic Proceedings|January 7, 2019
Postmarketing Safety-Related Modifications of Drugs Approved by the US Food and Drug Administration Between 1999 and 2014 Without Randomized Controlled TrialsDaniel Shepshelovich, Ariadna Tibau, Hadar Goldvaser, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Expert Opinion on Drug Safety|January 23, 2023
Evaluating the Impact of Black Box Warning Updates on the Reporting of Drug-Related Adverse Events: a Cross Sectional Study of the FAERS DatabaseYarden Yavne, Reut Amar Shamir, Michael Shapiro, et al.
Rheumatology (Oxford, England)|March 25, 2021
Quality evaluation of the underlying evidence in the updated treatment recommendations for systemic lupus erythematosusYarden Yavne, Yonatan Edel, Julia Berman, et al.
Acta Haematologica|August 17, 2018
Agranulocytosis Associated with Waldenström MacroglobulinemiaIuliana Vaxman, Daniel Shepshelovich, Lucille Hayman, et al.
The American Journal of Medicine|November 10, 2015
High Lung Cancer Incidence in Heavy Smokers Following Hospitalization due to PneumoniaDaniel Shepshelovich, Hadar Goldvaser, Yonatan Edel, et al.
The American Journal of Cardiology|July 19, 2020
Effect of Ticagrelor on Reducing the Risk of Gram-Positive Infections in Patients With Acute Coronary SyndromeLior Lupu, Daniel Shepshelovich, Shmuel Banai, et al.
Breast Cancer Research and Treatment|April 1, 2019
Toxicity and clinical outcomes of partial breast irradiation compared to whole breast irradiation for early-stage breast cancer: a systematic review and meta-analysisYasmin Korzets, Anthony Fyles, Daniel Shepshelovich, et al.
Mayo Clinic Proceedings|November 6, 2019
Undisclosed Financial Conflicts of Interest of Authors of Clinical Drug Trials Published in Influential Medical Journals: A Cohort StudyNoam Tau, Tzippy Shochat, Anat Gafter-Gvili, et al.
The Journal of Antimicrobial Chemotherapy|June 2, 2021
Concordance between the results of randomized and non-randomized interventional clinical trials assessing the efficacy of drugs for COVID-19: a cross-sectional studyDaniel Shepshelovich, Dafna Yahav, Ronen Ben Ami, et al.
Drug Safety|January 25, 2024
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic ReviewBronya Calvarysky, Idit Dotan, Daniel Shepshelovich, et al.
Mayo Clinic Proceedings|January 7, 2019
Postmarketing Safety-Related Modifications of Drugs Approved by the US Food and Drug Administration Between 1999 and 2014 Without Randomized Controlled TrialsDaniel Shepshelovich, Ariadna Tibau, Hadar Goldvaser, et al.
Pageof 10